Clearstead Trust’s Transmedics TMDX Stock Holding History

Clearstead Trust’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15	Closed	-$1.68K	–	1507
2025 Q3	$1.68K	Hold	15	–	–	﹤0.01%	1048
2025 Q2	$2.01K	Buy	+15	New	+$1.65K	﹤0.01%	950

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Clearstead Trust's TMDX Position: Q4 2025 in Review

Clearstead Trust sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 15 shares — an estimated $1.68K sold.

Clearstead Trust first reported a position in TMDX in Q2 2025 and held it in 2 quarters. The position peaked at $2.01K in Q2 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

Clearstead Trust reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 15 Transmedics shares in Q4 2025, an estimated $1.68K.
Clearstead Trust first reported a position in Transmedics in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Transmedics position peaked at $2.01K in Q2 2025.
428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.